152 related articles for article (PubMed ID: 12894483)
21. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
Fenoll A; Aguilar L; Robledo O; Giménez MJ; Tarragó D; Granizo JJ; Gimeno M; Coronel P
J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681
[TBL] [Abstract][Full Text] [Related]
22. A comparison of cefditoren pivoxil and amoxicillin/ clavulanate in the treatment of community-acquired pneumonia: a multicenter, prospective, randomized, investigator-blinded, parallel-group study.
Fogarty CM; Cyganowski M; Palo WA; Hom RC; Craig WA
Clin Ther; 2002 Nov; 24(11):1854-70. PubMed ID: 12501879
[TBL] [Abstract][Full Text] [Related]
23. Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to cefditoren, and provisional interpretive criteria.
Fuchs PC; Barry AL; Brown SD
Diagn Microbiol Infect Dis; 2000 Aug; 37(4):265-9. PubMed ID: 10974578
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
Jones RN; Fritsche TR; Sader HS
Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
[TBL] [Abstract][Full Text] [Related]
25. Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness.
Soriano F; Cafini F; Aguilar L; Tarragó D; Alou L; Giménez MJ; Gracia M; Ponte MC; Leu D; Pana M; Letowska I; Fenoll A
J Antimicrob Chemother; 2008 Dec; 62(6):1234-40. PubMed ID: 18799472
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial activity among multidrug-resistant Streptococcus pneumoniae isolated in the United States, 2001-2005.
Thornsberry C; Brown NP; Draghi DC; Evangelista AT; Yee YC; Sahm DF
Postgrad Med; 2008 Sep; 120(3 Suppl 1):32-8. PubMed ID: 18931469
[TBL] [Abstract][Full Text] [Related]
27. A national longitudinal study evaluating the activity of cefditoren and other antibiotics against non-susceptible Streptococcus pneumoniae strains during the period 2004-20 in Spain.
Sempere J; González-Camacho F; Domenech M; Llamosí M; Del Río I; López-Ruiz B; Gimeno M; Coronel P; Yuste J
J Antimicrob Chemother; 2022 Mar; 77(4):1045-1051. PubMed ID: 35045160
[TBL] [Abstract][Full Text] [Related]
28. Cefditoren pivoxil versus cefpodoxime proxetil for community-acquired pneumonia: results of a multicenter, prospective, randomized, double-blind study.
van Zyl L; le Roux JG; LaFata JA; Volk RS; Palo WA; Flamm R; Hom RC
Clin Ther; 2002 Nov; 24(11):1840-53. PubMed ID: 12501878
[TBL] [Abstract][Full Text] [Related]
29. In vitro activity of cefditoren versus other antibiotics against S. pneumoniae clinical strains isolated in Italy.
Tempera G; Furneri PM; Ferranti C; Genovese C; Ripa S; Ungheri S; Nicoletti G
Int J Immunopathol Pharmacol; 2010; 23(3):833-40. PubMed ID: 20943054
[TBL] [Abstract][Full Text] [Related]
30. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.
Jacobs MR; Felmingham D; Appelbaum PC; Grüneberg RN;
J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398
[TBL] [Abstract][Full Text] [Related]
31. Emergence of extremely high penicillin and cefotaxime resistance and high-level levofloxacin resistance in clinical isolates of Streptococcus pneumoniae in Hungary.
Glatz K; Szabó D; Szabó G; Boriszova D; Rozgonyi F
J Antimicrob Chemother; 2001 Nov; 48(5):731-4. PubMed ID: 11679565
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of CS-834 against experimental pneumonia caused by penicillin-susceptible and -resistant Streptococcus pneumoniae in mice.
Fukuoka T; Kawada H; Kitayama A; Koga T; Kubota M; Harasaki T; Kamai Y; Ohya S; Yasuda H; Iwata M; Kuwahara S
Antimicrob Agents Chemother; 1998 Jan; 42(1):23-7. PubMed ID: 9449255
[TBL] [Abstract][Full Text] [Related]
33. Ceftaroline activity against organisms isolated from respiratory tract infections in USA hospitals: results from the AWARE Program, 2009-2011.
Flamm RK; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2014 Apr; 78(4):437-42. PubMed ID: 24582578
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity of cefditoren: antimicrobial efficacy against major respiratory pathogens from Asian countries.
Lee MY; Ko KS; Oh WS; Park S; Lee JY; Baek JY; Suh JY; Peck KR; Lee NY; Song JH
Int J Antimicrob Agents; 2006 Jul; 28(1):14-8. PubMed ID: 16777383
[TBL] [Abstract][Full Text] [Related]
35. Activity of ceftaroline against serotyped Streptococcus pneumoniae isolates from Europe and South Africa associated with community-acquired bacterial pneumonia (2007-08).
Morrissey I; Leakey A
J Antimicrob Chemother; 2012 Jun; 67(6):1408-12. PubMed ID: 22357801
[TBL] [Abstract][Full Text] [Related]
36. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
Jones RN; Sader HS; Stilwell MG; Fritsche TR
Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
[TBL] [Abstract][Full Text] [Related]
37. [Antimicrobial resistance of Streptococcus pneumoniae, 2003-2009].
Năstase E; Dorneanu O; Dorobăţ C
Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):536-41. PubMed ID: 21870753
[TBL] [Abstract][Full Text] [Related]
38. Pneumococcal antimicrobial resistance: the problem in Hungary.
Marton A
Clin Infect Dis; 1992 Jul; 15(1):106-11. PubMed ID: 1617049
[TBL] [Abstract][Full Text] [Related]
39. Comparative activity of oral and parenteral cephalosporins tested against multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1997-2003).
Pottumarthy S; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Feb; 51(2):147-50. PubMed ID: 15698723
[TBL] [Abstract][Full Text] [Related]
40. In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model.
Moine P; Vallée E; Azoulay-Dupuis E; Bourget P; Bédos JP; Bauchet J; Pocidalo JJ
Antimicrob Agents Chemother; 1994 Sep; 38(9):1953-8. PubMed ID: 7811003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
